Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Phu Truong (NPI 1558323758)

Field	Value
Entity Type	Individual
Organization	Phu Truong
Address	3243 E Murdock St Ste 300
City	Wichita
State	KS
ZIP	67208
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	April 4, 2006

Payer Source	Total Paid
Medicare	$4.1M
Medicaid	$0

Key Findings

PHU TRUONG’s billing mix is characteristically hematology/oncology-focused, dominated by high-volume injectable cancer therapies and infusion services. The top Medicare drugs billed include J9271 (pembrolizumab) with $1.4M revenue (37.5% of this provider's total Medicare revenue), J9299 (nivolumab) with $542.3K revenue (14.2%), and J0897 (denosumab) with $296.4K revenue (7.7%), and chemotherapy administration and imaging codes (96413, 78815) also appear on the top-25 list, indicating an integrated infusion and treatment workflow.

Revenue is highly concentrated in a few immunotherapy and supportive-care agents: the precomputed top-three codes account for 59.4% of this provider’s total Medicare revenue. That concentration suggests business sensitivity to utilization or pricing changes for pembrolizumab, nivolumab, and denosumab specifically.

Payer mix is effectively single-payor: lifetime Medicare revenue is $4.1M while there is no Medicaid billing on file. This means the provider’s publicly reported outpatient infusion and oncology services are heavily dependent on Medicare reimbursement flows rather than state Medicaid volume.

For pembrolizumab (J9271) PHU TRUONG is a high-volume national player: J9271 shows 33.4K claims and $1.4M revenue and ranks #83 of 1841 providers nationally (95th percentile; notably above typical national volume for this code). This places the provider well above typical national volume for this high-cost immunotherapy relative to peers.

The provider shows mixed competitive standing across other top drugs: J0897 (denosumab) ranks #490 of 10057 (95th percentile; notably above typical national volume), indicating unusually strong denosumab utilization, while J9299 (nivolumab) ranks #119 of 505 (77th percentile), which is more typical and not an outlier. These rankings suggest the practice has particular strength in some supportive and bone-targeted agents in addition to immunotherapies.

Several procedural and E/M codes are statistical outliers versus national peers, signaling high procedure throughput in addition to drug administration. Notably, 96413 ranks in the 99th percentile and is labeled an "extreme outlier," 99213 ranks in the 99th percentile (extreme outlier), and 96367 ranks in the 99th percentile (notably above typical national volume), implying above-average volumes of chemotherapy administration, routine E/M visits, and additional infusion services.

The claims mix shows meaningful use of biosimilars and supportive biologics alongside branded immunotherapies, consistent with a modern oncology infusion practice. Examples include Q5107 (mvasi) with $124.4K revenue (3.2%), Q5108 (fulphila) with $70.1K revenue (1.8%), Q5115 (truxima) with $63.9K revenue (1.7%), and J1568 (IVIG/octagam) with $185.8K revenue (4.8%), indicating adoption of biosimilars and a portfolio of supportive care products.

The provider’s NPI was enumerated on 2006-04-04 (~20 years ago), indicating an established practice tenure. Coupled with the concentrated, high-volume oncology drug and infusion profile, this suggests a sustained, clinic-based oncology/injection service line in Wichita, KS rather than a newer or transient billing pattern.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

103 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	33,400	$40	$1.4M
J9299	Injection, nivolumab, 1 mg	23,580	$20	$542.3K
J0897	Injection, denosumab, 1 mg	15,600	$20	$296.4K
J2796	Injection, romiplostim, 10 micrograms	3,420	$70	$249.8K
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	5,630	$30	$185.8K
J9145	Injection, daratumumab, 10 mg	3,470	$50	$166.6K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	5,410	$20	$124.4K
J1627	Injection, granisetron, extended-release, 0.1 mg	20,000	$10	$100K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	970	$90	$91.1K
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	90	$1,070	$91K

Showing 1–10 of 103

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 103 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Phu Truong — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

103 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	7	20	28,900	$40	$1.1M
J9299	9	10	24,550	$20	$637.2K
J9145	9	10	6,660	$50	$394.7K
J2796	2	10	2,380	$70	$208.4K
J1568	3	10	3,690	$30	$129K
Q5107	2	10	4,440	$20	$106.5K
Q5115	8	10	2,340	$30	$92.9K
J0897	9	180	2,160	$20	$81.5K
J1627	3	10	15,500	$1	$78.7K
J1439	7	10	41,250	$1	$66.1K

Showing 1–10 of 103

Related Providers

Other providers that share a Tax Identification Number (TIN) with Phu Truong, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Dennis Moore	KS	Hematology & Oncology Physician	$6.7M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Shaker Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Nassim Nabbout	KS	Hematology & Oncology Physician	$4.2M	$0
Quoc Truong	KS	Hematology & Oncology Physician	$3.9M	$0
Joseph Moore	KS	Hematology & Oncology Physician	$3.6M	$0

Nearby Providers

Other providers in the same ZIP code as Phu Truong, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ascension Medical Group Via Christi, PA	KS	Multi-Specialty Clinic/Center	$0	$21.2M
County Of Sedgwick	KS	Case Manager/Care Coordinator	$0	$15.5M
County Of Sedgwick	KS	Psychiatry Physician	$0	$5.9M
Great Plains Dental Group, LLC	KS	General Practice Dentistry	$0	$5.8M
Mental Health America Of South Central Kansas, Inc.	KS	Community/Behavioral Health Agency	$0	$5.7M
Kidspace Pediatric Dentistry,p.a	KS	Pediatric Dentistry	$0	$4.4M
Cerebral Palsy Research Foundation Of Kansas, Inc	KS	Non-emergency Medical Transport (VAN)	$0	$4.3M
Grace Home Care, LLC	KS	Home Health Agency	$0	$4M
Alan Hromas	KS	Retina Specialist (Ophthalmology) Physician	$2.1M	$0
Associates In Womens Health PA	KS	Obstetrics & Gynecology Physician	$0	$2.1M

Phu Truong — Billing Profile & Reimbursement Data

Sign up for Phu Truong — Billing Profile & Reimbursement Data policy alerts

Phu Truong — Billing Profile & Reimbursement Data

Sign up for Phu Truong — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References